Statement, November 2017
Statement by the South Centre on EU-MERCOSUR Trade Negotiations
EU-MERCOSUR Trade Negotiations must not impose TRIPS Plus provisions on Protection and Enforcement of Intellectual Property Rights
Access to Medicines
Research Paper 82, November 2017
The International Debate on Generic Medicines of Biological Origin
The debate on generic medicines is not new. What makes it different today is that attacks levelled against biological products are couched in ever more “technical” and abstruse language that confuses even the World Health Organization (WHO).
Policy Brief 45, October 2017
The Value Added of the United Nations General Assembly High–Level Political Declaration on Antimicrobial Resistance
In September 2016, the United Nations General Assembly (UNGA) in New York held a dedicated meeting to muster strong political commitment for an effective global response to the problem of antimicrobial resistance (AMR). As a result, a High-Level Political Declaration on Antimicrobial Resistance was adopted.
South Centre News on AMR 9, 24 October 2017
G77 and China highlights priorities for tackling AMR
DIIP Monthly Update – August 2017
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of August 2017.
South Centre News on AMR 4, 6 September 2017
Growing impetus to making AMR an integral issue in the 2030 Agenda for Sustainable Development
South Centre News on AMR 3, 28 August 2017
Antibiotic-resistant gonorrhea crisis: new drugs needed
South Centre News on AMR 2, 22 August 2017
State of discussion on AMR action, two years after the WHA Global Plan
South Centre News on AMR 1, 9 August 2017
Civil society and South Centre call for urgent actions to tackle AMR and ensure access and new innovation models
DIIP Monthly Update – July 2017
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of July 2017.
Research Paper 62R, July 2017
Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines (revised)
Most free trade agreements (FTAs) signed by the United States, the European Union and the members of the European Free Trade Association (EFTA) in the last 15 years contain chapters on intellectual property rights with provisions applicable to pharmaceuticals. Such provisions considerably expand the rights recognized to pharmaceutical companies under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) established in the context of the World Trade Organization (WTO). (more…)
Research Paper 78, July 2017
Intellectual Property, Public Health and Access to Medicines in International Organizations
This South Centre research paper by Dr. German Velasquez describes and analyses the mandate, programmes, strategies, and activities that different international organizations such as WHO, WTO, WIPO, UNCTAD, UNDP, UNAIDS, the UN Human Rights Council, and the UN Secretary-General’s High Level Panel (UNHLP) on access to medicines have undertaken on the subject of access to medicines, intellectual property, international trade rules and human rights.